HHS Secretary Becerra’s Statement on the FDA’s Approval of Wezlana

02. November 2023 EHR, EMR, Health, HIPAA 0

Today’s action by the FDA is a welcome step forward to approve a biosimilar for a drug taken by tens of thousands of Americans.

Powered by WPeMatico